Short Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Increases By 43.1%

bioMérieux S.A. (OTCMKTS:BMXMF) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 154,600 shares, a growth of 43.1% from the February 13th total of 108,000 shares. Based on an average trading volume of 1,300 shares, the short-interest ratio is currently 118.9 days. Approximately 0.1% of the shares of the stock are sold short.

bioMérieux Price Performance

bioMérieux stock opened at $123.74 on Monday. The firm has a 50 day simple moving average of $117.41 and a 200-day simple moving average of $113.29. The company has a current ratio of 2.21, a quick ratio of 1.20 and a debt-to-equity ratio of 0.10. bioMérieux has a 12-month low of $93.50 and a 12-month high of $126.64.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.